Areas of Focus
- Tumor Microenvironment
- Tumor Immunology
- Precision Medicine
Work Experience
- 2017-2019 - Indiana University School of Medicine - Research Assistant Professor
- 2011-2017 - MD Anderson Cancer Center - Postdoctoral Fellow
- Current - Zhejiang University School of Basic Medical Sciences - PI
- Current - Zhejiang University Second Affiliated Hospital - Joint Professor
Academic Background & Achievements
- 2017-2019 Research Assistant Professor: Indiana University School of Medicine
- 2011-2017 Postdoctoral Fellow: MD Anderson Cancer Center
- 2006-2011 PhD in Microbiology: Shanghai Pasteur Institute, Chinese Academy of Sciences
- Achievement: Discovered RIPK2 as a potential immunotherapy target for pancreatic cancer (Cancer Discovery 2023)
- Achievement: Identified therapeutic targets for TP53/17p deletion tumors and pioneered antibody-drug conjugates for precision therapy (Nature 2015)
- Achievement: Developed a nanoparticle-based precision drug delivery system for triple-negative breast cancer (Nature Nanotechnology 2019)
- Achievement: Revealed pathogenic mechanisms and potential therapeutic targets of 17q23 amplification in breast cancer (Nature Communications 2019)
Publications
- RIPK2 as a potential immunotherapy target for pancreatic cancer, Yunhua Liu, 2023
- Therapeutic targets for TP53/17p deletion tumors and antibody-drug conjugates for precision therapy, Yunhua Liu, 2015
- Nanoparticle-based precision drug delivery system for triple-negative breast cancer, Yunhua Liu, 2019
- Pathogenic mechanisms and potential therapeutic targets of 17q23 amplification in breast cancer, Yunhua Liu, 2019